- Kiplinger•9 days ago
When investors are on the hunt for income-driving dividend stocks, they often gravitate toward utilities or consumer staples names. Conversely, pharmaceutical stocks are rarely seen as effective dividend stocks. Although drugs are also relatively non-cyclical, these stocks are often impacted by an ever-changing regulatory environment and the ever-changing strength or weakness of a drugmaker's portfolio and pipeline.
- Motley Fool•16 days ago
A net cash position is a rarity for large pharmaceutical companies, but these two may have exceptional financial flexibility because of it.
- Capital Cube•17 days ago
Categories: Yahoo Finance Get free summary analysis Novo Nordisk A/S reports financial results for the year ended December 31, 2016. Highlights Gross margins widened from 84.55% to 84.63% compared to the same period last year, operating (EBITDA) margins now 45.53% from 45.30%. Change in operating cash flow of 26.18% compared to same period last year is about the ... Read more (Read more...)
NONOF : Summary for NOVO NORDISK A/S B - Yahoo Finance
Novo Nordisk A/S (NONOF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||35.73 - 35.76|
|52 Week Range||31.07 - 47.95|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.64|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|